메뉴 건너뛰기




Volumn 109, Issue 3, 2007, Pages 851-852

B-ware of allosensitized graft rejection

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; IMMUNOGLOBULIN;

EID: 33846857771     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-11-056887     Document Type: Note
Times cited : (3)

References (6)
  • 1
    • 12144289379 scopus 로고    scopus 로고
    • Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia
    • Iannone R, Casella JF, Fuchs EJ, et al. Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. Biol Blood Marrow Transplant. 2003;9:519-528.
    • (2003) Biol Blood Marrow Transplant , vol.9 , pp. 519-528
    • Iannone, R.1    Casella, J.F.2    Fuchs, E.J.3
  • 2
    • 0017212662 scopus 로고
    • Direct and antibody-dependent cell-mediated cytotoxicity against HLA identical sibling lymphocytes: Correlation with marrow graft rejections
    • Warren RP, Storb R, Weiden PL, Mickelson EM, Thomas ED. Direct and antibody-dependent cell-mediated cytotoxicity against HLA identical sibling lymphocytes: correlation with marrow graft rejections. Transplantation. 1976;22:631-635.
    • (1976) Transplantation , vol.22 , pp. 631-635
    • Warren, R.P.1    Storb, R.2    Weiden, P.L.3    Mickelson, E.M.4    Thomas, E.D.5
  • 3
    • 33645454939 scopus 로고    scopus 로고
    • Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation
    • Srinivasan R, Takahashi Y, McCoy JP, et al. Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation. Br J Haematol. 2006;133:305-314.
    • (2006) Br J Haematol , vol.133 , pp. 305-314
    • Srinivasan, R.1    Takahashi, Y.2    McCoy, J.P.3
  • 4
    • 33751166389 scopus 로고    scopus 로고
    • Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients
    • Xu H, Chilton PM, Tanner MK, et al. Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients. Blood. 2006;108:3611-3619.
    • (2006) Blood , vol.108 , pp. 3611-3619
    • Xu, H.1    Chilton, P.M.2    Tanner, M.K.3
  • 5
    • 0034721477 scopus 로고    scopus 로고
    • Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into crossmatch-positive recipients
    • Montgomery RA, Zachary AA, Racusen LC, et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into crossmatch-positive recipients. Transplantation. 2000;70:887-895.
    • (2000) Transplantation , vol.70 , pp. 887-895
    • Montgomery, R.A.1    Zachary, A.A.2    Racusen, L.C.3
  • 6
    • 11844258256 scopus 로고    scopus 로고
    • Rituximab inhibits the in vivo primary and secondary antibody response to a neoantigen, bacteriophage phiX174
    • Bearden CM, Agarwal A, Book BK, et al. Rituximab inhibits the in vivo primary and secondary antibody response to a neoantigen, bacteriophage phiX174. Am J Transplant. 2005;5:50-57.
    • (2005) Am J Transplant , vol.5 , pp. 50-57
    • Bearden, C.M.1    Agarwal, A.2    Book, B.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.